1. Researchers call out Gilead over diversity of remdesivir trials — Bristol-Myers commits $300M to combat racial disparities — Goldman predicts at least one coronavirus vaccine approval before the end of 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Welcome to Florida!

Discussion in 'Blue Belt Technologies' started by Anonymous, Sep 7, 2014 at 8:18 PM.

  1. Anonymous

    Anonymous Guest

    Now that you've spent some time with your new business partners in Florida, have you ever seen a more unprofessional, classless or disorganized bunch of underachievers? Modeled in the same likeness as our illustrious POS DOS.

    Good Luck in Strako's backyard!